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Almost all children with presumed congenital heart disease
are screened by pediatric cardiologists who take a history,
do a physical examination and then decide on what inves-
tigations are needed. Sometimes none are required and
sometimes electrocardiograms, chest radiographs and echo-
cardiograms are used to make a diagnosis and assess the
severity of the lesion. Often nothing further is needed; for
example, if there is a small ventricular septal defect or minor
pulmonary stenosis, the patient is followed up carefully. At
other times, cf}rdiac catheterization and angiognlphy are
performed to clarify a diagnosis, obtain a better assessment
of severity or pbtain detailed anatomic information neces-
sary to plan for \,:orrective surgery. These procedures provide
some or all of the following information:
I) Cardiac output.,
2) The sites of srlUnting and the amount shunted at each
site.
3) Pressures in v<\rious chambers and vessels.
4) Chamber volumes and time course of volume changes
during the cardjac cycle.
5) Abnormalities of wall motion.
6) Cardiac metabolisfl\.
All of this information is obtained at rest and, sometimes,
after physiologic or pharmacologic interventions like ex-
ercise, pacing or infusion of vasoactive agents. Additional
data which can be obtained during catheterization and which
can be quite important for management decisions include:
7) Abnormalities in size and distribution of major vessels
entering or leaving the heart.
8) Precise shape of chambers, especially the ventricular
inflow and outflow tracts.
9) Sequence and timing of electrical depolarization, pres-
ence of accessory or dual conduction pathways, abnor-
mal irritability.
In addition there are therapelltic uses of cardiac cathe-
terization including balloon atrial septostomy, balloon di-
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lation of valves or stenoses, closure of atrial septal defects,
patent ductus arteriosus or aorticopulmonary collateral ves-
sels. These are, however, substitutes for cardiovascular sur-
gery and not diagnostic procedures, and as such, they will
not be considered further here.
Drawbacks of Invasive Procedures
Although cardiac catheterization and angiography are very
useful procedures that have helped thousands of children,
they have many drawbacks.
1) The proced\lfe is uncomfortable and usually causes anxiety.
2) Introducing catheters into the cardiovasclllar system can
cause morbidity and, on rare occasions, death.
3) Strenuous exercise is difficult to do with catheters in
place, particularly in the ventricles.
4) Assessment of metabolism is restricted to certain global
metabolic functions that are reflected by ch,mges in coro-
nary sinus concentrations and fluxes of certain metabolites.
5) The procedure requires costly equipmenf. A new cardiac
catheterization laboratory costs about $1 to 1.5 million.
6) The procedure usually requires abQut I to 3 hours, and
several highly trained professionals are needed.
Becm-1se of these problems, cardiac catheterization and
angiography are usually reserved for the more serious le-
sions and repeated only when absolutely necessary. We,
therefore, lack information about minor or moderate lesions,
and follow-up studies in the same patient are limited, even
though both of these types of studies could provide a great
deal of infoqnation useful to those particular patients and
others who hav~ those lesions.
Role of Noninvasive Techniques
In an attempt to overcome these difficulties, much at-
tention has been paid to methods that are noninvasive or
minimally invasive, safe, less time-consuming, cheaper,
available at the bedside, usable during maximal exercise
and capable of assessing regional cardiac metabolism. It is
clear that the likelihood of finding a single method with all
these virtues is remote and that we will have to select specific
methods to solve particular problems. For example, when
we need to decide on the optimal time for valve surgery in
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patients with aortic stenosis or aortic incompetence, ideally,
we would like to know when myocardial cells (specifically,
subendocardial muscle cells) become ischemic or even die.
At present, electrocardiographic features of subendocardial
ischemia probably yield this information, but they may well
occur late or only with severe ischemias. During cardiac
catheterization, measuring lactate efflux in the coronary si-
nus during exercise would demonstrate myocardial ischemia
somewhere in the left ventricle, but this is relatively insen-
sitive and is usually not of value at rest. Therefore, we
resort to indirect evidence of possible myocardial damage;
that is, very high left ventricular end-diastolic pressure,
increased left ventricular systolic or diastolic volumes, de-
creased ejection fraction or high systolic pressure differ-
ences across a stenotic valve,
The continued arguments about what critical levels of
these measurements we should use attests to the crudity of
these indexes. Therefore, alternative methods not only should
be noninvasive, but should be capable of giving information
not obtainable by current cardiac catheterization procedures.
We need some method that allows us to assess regional
myocardial metabolism during exercise (for example, nu-
clear magnetic resonance imaging or positron emission to-
mography) or to detect subendocardial fibrosis (for example,
nuclear magnetic resonance imaging, positron emission to-
mography, echocardiography or computed tomography). By
contrast, in the preoperative assessment of an infant with
tetralogy of Fallot, we would like to know the precise anat-
omy of the right ventricular outflow tract and the size of
the main pulmonary artery and the first few orders of major
branches. For this problem, an accurate imaging method
capable of showing intrapulmonary vessels mandates the
use of digital subtraction angiography, computed tomog-
raphy or nuclear magnetic resonance rather than echocardi-
ography. Therefore, it is virtually certain that several tech-
niques will be needed, even though ultimately one or more
of them may become redundant.
Costs
Before proceeding with a discussion of the different di-
agnostic modalities, some issues relative to cost must be
raised. First, we are talking about a relatively large number
of patient examinations. Congenital heart disease occurs in
about I per 100 live births, and to this we must add 2 or 3
infants per 100 live births who have a bicuspid aortic valve.
This is certainly less than the incidence of coronary artery
disease and hypertension, but because these acquired dis-
eases usually emerge later in life, the number of patient
years of heart disease is not much different for congenital
and acquired heart disease. Furthermore, whereas there is
reason to believe that in another 20 years it may be possible
to control or prevent coronary artery and hypertensive dis-
ease, congenital heart disease is likely to increase slowly in
incidence and prevalence as more of these children survive
to have their own children in whom the incidence of heart
disease is increased about three to five fold. The second
issue pertaining to cost is that we should compute the total
cost of the various techniques, including the cost of not
doing them and the cost to society of having sick rather than
healthy people. Thus, if we can perform more and earlier
examinations by replacing cardiac catheterization with a
noninvasive test that has the same cost for capital equipment,
we will learn more about these diseases and eventually save
money. If the examinations can be done more quickly so
that more patiertts can be studied per week, then the cost
per procedure can be reduced, thereby amortizing the ex-
penditures for equipment more quickly. Finally, actuarial
studies of congenital heart disease have shown that restoring
to health a child who will become a wage earner, tax payer
and supporter (rather than user) of the Social Security sys-
tem, more than repays the costs to society of any necessary
diagnostic studies and surgery.
To support these statements, consider the following
information:
I) Cardiac catheterization rates in infancy have been esti-
mated at 2,500 to 2,700 per million live births (1,2). At
all ages in childhood, the estimate is 5,700 per million
live births (National Heart, Lung, and Blood Institute
Task Force on Prevention and Treatment of Cardiovas-
cular Disease in the Young).
2) Rough estimates of the costs of cardiac catheterization
for these children yield an annual cost of about $10 to
30 million per million live births, depending on duration
of hospital stay and hospital charges.
3) Costs of cardiac surgery for patients with congenital heart
disease are of the order of $250 million annually.
4) Estimated loss of earnings due to premature death from
congenital heart disease was about $720 million in 1975
(3, National Heart, Lung, and Blood Institute Task Force
on Prevention and Treatment of Cardiovascular Disease
in the Young).
Thus, despite the relative infrequency of congenital heart
disease (about 1 per 100 live births), the annual cost of
diagnosis and treatment is very high and the potential loss
of earnings because of imtreated heart disease is even higher.
The economic incentive to develop better methods of di-
agnosis and treatment is, therefore, very great.
Techniques
With these issues in mind, let us consider the various
techniques discussed at this conference, and divide them
into three groups:
I) Ultrasound.
2) Nuclear cardiology and digital subtraction angiography.
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3) a. Cinecomputed tomography, dynamic spatial recon-
struction.
b. Nuclear magnetic resonance, positron emission to-
mography.
Ultrasound
These techniques are already extensively used and have
proven value. The equipment costs less than $100,000 and
is portable. The examination does not take a long time, does
not require many people to do it and the cost per examination
is less than $300. Results are obtained in real time and are
usually available immediately (although some subsequent
data processing may be advantageous). By providing cross-
sectional images, the problems of superimposition that be-
devil "angiographic" silhouette techniques are avoided.
Anatomic structure is usually well shown, although not in
a three-dimensional format, and volume, volume changes,
wall mass, wall thickness and wall motion of the left ven-
tricle are fairly accurately obtained. Similar values for the
right ventricle or atria are less easily obtained because of
their irregular shapes. In addition, resolution of endocardial
structures may be imperfect, with resultant errors of mea-
surement. Furthermore, measurements during severe exer-
cise are difficult. The technique does not allow accurate
measurements of pressure (nor does any other noninvasive
technique). It is the only technique that can reasonably be
used to study the fetal heart, being completely safe and
noninvasive. It does not yield metabolic data, but by dis-
criminating between different types of tissue, may provide
some regional information.
Adding pulsed or continuous wave Doppler capabilities
to echocardiography has added valuable new dimensions,
including semiquantitative measurements of flows in various
vessels, detection of clinically important backflow or valvar
regurgitation, estimates of stenotic valve areas and detection
of abnormal turbulence.
As a group of techniques, this one comes nearest to the
ideal noninvasive technique. More work on tissue signatures
is needed, as are studies in three-dimensional reconstruction
and improved resolution. The use of safer contrast agents,
although converting it from a noninvasive to a minimally
invasive technique, may help to define left-sided structures
and shunts better. All these advances should be encouraged
promptly because they are likely to be put rapidly into ex-
tensive clinical use. Finally, although direct measurements
of pressures by ultrasound are not yet available, it is entirely
feasible that some application of ultrasound might be found
to measure pressures, and this should be encouraged
vigorously.
Nuclear Cardiology and Digital
Subtraction Angiography
These techniques are simpler and less invasive means of
obtaining better information about volumes, volume changes,
shunt quantitation and even structure and wall motion than
regular angiocardiography. Because counting gamma emis-
sions from a ventricle or videodensitometry of contrast me-
dium does not make use of geometric approximations, ven-
tricular ejection fractions are well measured at rest and during
exercise provided that the difficulty of superimposition of
other structures can be avoided; this can be done for the
left ventricle fairly easily, but is more difficult for the right
ventricle. Digital subtraction angiographic techniques, whether
injection of contrast medium is given intravenously or into
the heart (when it is, of course, no longer a noninvasive
technique), allow reduction of the amount of contrast ma-
terial given; however, with the development of newer non-
toxic contrast agents, this is no longer the important con-
sideration that it once was. Adding more computing power
to digital subtraction angiographic systems expands their
ability to produce quantitative data regarding volumes, flow
and flow distribution and might not add too much to the
cost of the systems.
The other use of radionuclides, namely, myocardial scin-
tigraphy, is much more limited in pediatric cardiology. Thal-
lium-201 uptake as a marker for regional ischemia is not
often needed in infants and children. When it is, the poor
resolution of the technique makes all but the largest lesions
undetectable. Quantitation of regional flow is, of course,
not possible. Gallium-67 scans have potential value in de-
tecting myocarditis or infective endocarditis, but this is a
rare usage. Using indium-labeled platelets to detect myo-
cardial thrombi or thrombi forming on prosthetic valves
could be useful in a limited number of patients; little has
been done in the pediatric age group.
Newer Techniques
The third group of techniques involves the most expen-
sive and least portable methods, but does offer measure-
ments not available by other techniques. One subgroup in-
cludes computed tomographic techniques by Dynamic Spatial
Reconstruction or the newer generation of fast tomographic
scanners. These provide resolution, shape, volumes and
wall motion. With injection of contrast agents such tech-
niques may yield information about absolute or relative flows
to regions of the myocardium. They are largely unevaluated
in infants and children and, thus, not suitable for routine
use now. However, studies of their potentialities should be
encouraged.
The other subgroup includes positron emission tomog-
raphy and nuclear magnetic resonance imaging techniques.
The former has relatively poor resolution (especially in small
hearts) and will always be limited by the need for a cyclotron
on site, but it offers an unparalleled ability to explore myo-
cardial metabolism. The latter is perhaps the least invasive
of all imaging modalities except ultrasound, and offers the
prospect of high resolution definition of anatomy and per-
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haps of certain aspects of metabolism. The glimpse of the
future provided by the Conference is exciting, but clearly
it will be many years before the experiments being con-
ducted on small animals or isolated organs can be done on
patients. However, we must encourage fundamental studies
in this field and be alert to possibilities of applying the
methods to diagnostic problems in our patients.
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